Wells Fargo’s DiaMedica Therapeutics DMAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.1K | Buy |
14,652
+13,652
| +1,365% | +$53.2K | ﹤0.01% | 5048 |
|
|
2025
Q1 | $3.79K | Buy |
+1,000
| New | +$3.79K | ﹤0.01% | 5602 |
|
|
2024
Q2 | – | Sell |
-175
| Closed | -$485 | – | 6618 |
|
|
2024
Q1 | $485 | Buy |
175
+3
| +2% | +$8 | ﹤0.01% | 5892 |
|
|
2023
Q4 | $488 | Buy |
172
+9
| +6% | +$26 | ﹤0.01% | 5945 |
|
|
2023
Q3 | $421 | Buy |
163
+47
| +41% | +$121 | ﹤0.01% | 6025 |
|
|
2023
Q2 | $501 | Buy |
116
+4
| +4% | +$17 | ﹤0.01% | 6180 |
|
|
2023
Q1 | $171 | Buy |
112
+2
| +2% | +$3 | ﹤0.01% | 6495 |
|
|
2022
Q4 | $174 | Buy |
110
+3
| +3% | +$5 | ﹤0.01% | 6327 |
|
|
2022
Q3 | $0 | Sell |
107
-70
| -40% | – | ﹤0.01% | 6440 |
|
|
2022
Q2 | $0 | Buy |
177
+14
| +9% | – | ﹤0.01% | 6606 |
|
|
2022
Q1 | $0 | Buy |
163
+1
| +0.6% | – | ﹤0.01% | 6750 |
|
|
2021
Q4 | $1K | Buy |
162
+47
| +41% | +$290 | ﹤0.01% | 6426 |
|
|
2021
Q3 | $0 | Buy |
115
+10
| +10% | – | ﹤0.01% | 6684 |
|
|
2021
Q2 | $0 | Sell |
105
-1
| -0.9% | – | ﹤0.01% | 6605 |
|
|
2021
Q1 | $1K | Sell |
106
-2,000
| -95% | -$18.9K | ﹤0.01% | 6327 |
|
|
2020
Q4 | $21K | Buy |
2,106
+31
| +1% | +$309 | ﹤0.01% | 5606 |
|
|
2020
Q3 | $8K | Buy |
2,075
+8
| +0.4% | +$31 | ﹤0.01% | 5614 |
|
|
2020
Q2 | $14K | Buy |
2,067
+2,000
| +2,985% | +$13.5K | ﹤0.01% | 5449 |
|
|
2020
Q1 | $0 | Buy |
+67
| New | – | ﹤0.01% | 5921 |
|